Home  /  Resource Library  /  Long Term Outcomes of Venetoclax Therapy for Complex Karyotype Relapsed/Refractory Chronic Lymphocytic Leukemia

Long Term Outcomes of Venetoclax Therapy for Complex Karyotype Relapsed/Refractory Chronic Lymphocytic Leukemia

Study examined long term outcomes for relapsed CLL patients who have complex karyotype treated with venetoclax.